• SPX
  • $5,995.67
  • 0.38 %
  • $22.57
  • DJI
  • $43,988.98
  • 0.59 %
  • $259.63
  • N225
  • $39,500.37
  • 0.3 %
  • $118.96
  • FTSE
  • $8,072.39
  • -0.84 %
  • -$68.35
  • IXIC
  • $19,286.78
  • 0.09 %
  • $17.32

FDA approves a new Alzheimer's drug. What to know about Eli Lilly's Kisunla

By USA Today   |   Jul 2, 2024 at 06:20 PM EST
FDA approves a new Alzheimer's drug. What to know about Eli Lilly's Kisunla

An FDA panel recommended the approval of a new Alzheimer's drug, donanemab, which slows cognitive decline. The drug, marketed as Kisunla, removes beta-amyloid plaques in the brain.

Read More

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.